FDA Approves Unknown Drug — SANKALP LIFECARE
Sankalp Lifecare announced FDA approval for its new drug application, a milestone that is expected to diversify the company's revenue streams and strengthen its competitive positioning within the generic pharmaceutical market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day